SOURCE: Kantar Health

Kantar Health

May 04, 2011 10:53 ET

Kantar Health Thought Leaders to Present at PBIRG

NEW YORK, NY--(Marketwire - May 4, 2011) - Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that two of its thought leaders will be presenting at the Pharmaceutical Business Intelligence Research Group (PBIRG) Annual General Meeting May 15-18 at the JW Marriott San Antonio Hill Country in San Antonio, Texas.

Sherif Shafick, General Manager, Middle East and Africa, and Wael Raafat, Business Development Director, Middle East, will present "Will MENA Become the New BRIC?" from 1:30 to 2:30 and again from 3:00 to 4:15 on Monday, May 16. The presentation will focus on the pharma industry's next big growth opportunity beyond BRIC countries -- the Middle East and North Africa (MENA). The presentation will help companies investing in this region gain a deeper understanding of:

  • Market growth in the MENA region
  • Diversity in the MENA region (economic, cultural and demographic)
  • Market research industry challenges facing the region
  • Expected effects of recent political changes

Mr. Shafick has worked in more than 20 countries in the MENA region helping healthcare companies develop strong brands. He was a Regional Business Development Director for Healthcare - Emerging Markets and Regional Manager of Healthcare in the Middle East and North Africa at TNS Healthcare. Before joining TNS Mr. Shafick worked in sales and marketing in the pharmaceutical and para-pharmaceutical industries.

Mr. Raafat has 14 years of pharmaceutical industry experience. His expertise includes client servicing, marketing research and expert understanding of the pharmaceutical industry gained through his sales and marketing career within leading pharmaceutical companies. At Kantar Health, Mr. Raafat is responsible for business development across the Middle East.

For more information about the PBIRG Annual General Meeting, visit the PBIRG website.

About Kantar Health (
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:

  • The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist -- or whatever combination of data you require
  • Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
  • A unique global source of KOLs for multiple therapy areas

Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. By uniting industry leaders MattsonJack, TNS Healthcare, Consumer Health Sciences and Ziment, we offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.

Contact Information

  • Contact Information
    For more information on Kantar Health, please contact
    Paula Paradise
    Vice President of Global Marketing
    Email Contact